Express News | Pillar Biosciences Receives CMS Coverage for FDA Approved Oncoreveal® Cdx Pan-Cancer Solid Tumor Ivd Kit

ReutersApr 3 10:00 ET

Pillar Biosciences Receives CMS Coverage for FDA Approved OncoReveal CDx Pan-Cancer Solid Tumor IVD Kit

PR NewswireApr 3 10:00 ET

ICBC's 2024 Pillar 3 Disclosure Highlights Risk Management and Capital Strategy

TipRanksMar 28 08:49 ET

Ees Europe: The Rise of Large-Scale Storage Systems – Driving Growth in the Storage Market and an Indispensable Pillar of the Energy Transition

BusinesswireMar 27 10:52 ET

Postal Savings Bank of China Releases 2024 Pillar 3 Disclosure Report on Capital Management

TipRanksMar 27 10:16 ET

Pillar To Go Ex-Dividend On March 28th, 2025 With 71 JPY Dividend Per Share

March 27th (Japan Standard Time) - $Pillar(6490.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 71 JPY dividend per share. The ex-dividend

Moomoo NewsMar 26 21:00 ET